Medicinova annual operating margin
2012
2021
2023
2025
Medicinova's operating margin was −3,242.47% for fiscal 2025.
View full Medicinova company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −3,242.47% | −2252.44 pp |
| 2023 | 2023-12-31 | −990.03% | −737.00 pp |
| 2021 | 2021-12-31 | −253.02% | +1110.75 pp |
| 2012 | 2012-12-31 | −1,363.77% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −554.31% | −439.62 pp |
| Q1 2026 | 2026-03-31 | −1,516.60% | +8088.57 pp |
| Q3 2025 | 2025-09-30 | −2,741.67% | −2736.63 pp |
| Q2 2025 | 2025-06-30 | −2,679.88% | +71538.54 pp |
| Q3 2023 | 2023-09-30 | −114.69% | +7007.27 pp |
| Q3 2021 | 2021-09-30 | −9,605.17% | −6785.27 pp |
| Q1 2021 | 2021-03-31 | −5.04% | +458.51 pp |
| Q1 2013 | 2013-03-31 | −74,218.42% | −72192.38 pp |
| Q4 2012 | 2012-12-31 | −7,121.96% | — |
| Q3 2012 | 2012-09-30 | −2,819.90% | — |
| Q2 2012 | 2012-06-30 | −463.55% | — |
| Q1 2012 | 2012-03-31 | −2,026.04% | — |
Across the available reported history, Medicinova's operating margin decreased from −990.03% to −3,242.47%, a change of −2252.44 percentage points. The latest reported quarter, Q2 2026, shows −554.31%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Medicinova filings at SEC.gov ↗